Exagen Inc. (XGN) Earnings History
Net Loss14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Exagen Inc. (XGN) Earnings Overview
As of June 24, 2026, Exagen Inc. (XGN) reported trailing twelve-month net income of -$20M, reflecting -12.0% year-over-year growth. The company earned $-0.85 per diluted share over the past four quarters, with a net profit margin of -30.0%.
Looking at the long-term picture, XGN's historical earnings data spans multiple years. The company achieved its highest annual net income of -$7M in fiscal 2012.
Exagen Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including CDNA (-$8M net income, -5.6% margin), NTRA (-$226M net income, -9.0% margin), VCYT ($88M net income, 12.8% margin), XGN has room to improve margins relative to the peer group. Compare XGN vs CDNA →
XGN Earnings vs Peers
Earnings metrics vs comparable public companies
XGN Historical Earnings Data (2012–2025)
13 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$20M | -32.0% | -$14M | $-0.93 | -30.0% | -21.1% |
| 2024 | -$15M | +36.2% | -$14M | $-0.83 | -27.2% | -24.5% |
| 2023 | -$24M | +50.0% | -$23M | $-1.34 | -45.1% | -43.5% |
| 2022 | -$47M | -76.5% | -$46M | $-2.77 | -104.0% | -101.1% |
| 2021 | -$27M | -60.9% | -$24M | $-1.68 | -55.6% | -49.8% |
| 2020 | -$17M | -38.6% | -$15M | $-1.32 | -39.8% | -36.2% |
| 2019 | -$12M | -50.2% | -$9M | $-0.96 | -29.8% | -23.0% |
| 2018 | -$8M | +68.7% | -$5M | $-127.16 | -24.7% | -15.0% |
| 2017 | -$26M | -33.6% | -$8M | $-406.81 | -95.6% | -29.2% |
| 2015 | -$19M | -28.0% | -$10M | $-305.48 | -106.9% | -57.9% |
| 2014 | -$15M | -11.0% | -$12M | $-265.79 | -128.4% | -99.1% |
| 2013 | -$13M | -84.3% | -$9M | $-251.43 | -441.8% | -299.3% |
| 2012 | -$7M | - | -$7M | $-206.86 | -790.9% | -737.1% |
Download Data
Export XGN earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
14+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
XGN — Frequently Asked Questions
Quick answers to the most common questions about buying XGN stock.
What is XGN earnings per share (EPS)?
XGN trailing twelve-month (TTM) diluted EPS is $-0.85, reflecting -12.0% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.
What is Exagen Inc.'s net income?
Exagen Inc. (XGN) trailing twelve-month net income is $-20M as of 2025. Earnings declined -12.0% year-over-year.
Is XGN profitable?
XGN is not currently profitable on a TTM basis, reporting a net loss of $-20M. Net margin is -30.0%. Investors should monitor for a return to profitability.
What is XGN's earnings growth rate?
XGN compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.
What are XGN's profit margins?
Exagen Inc. net profit margin is -30.0%, operating margin is -21.1%, and gross margin is +58.3%. Below-average margins reflect competitive or cost pressures. Return on Equity is -147.8%.
Is XGN growing earnings?
XGN earnings are declining — EPS fell -12.0% year-over-year. TTM net income dropped to $-20M. This contrasts with the 5-year CAGR of N/A.
What was XGN's best earnings year?
Exagen Inc.'s highest annual net income on record is $-7M, achieved in fiscal year 2012. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.
What were XGN's earnings last quarter?
XGN's most recent reported quarter was Q1 2026. Net income was $-4M with diluted EPS of $-0.17. For a full breakdown of all quarters, see the quarterly earnings table on this page.